Cargando…

TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis

Myelofibrosis (MF) is a progressive chronic myeloproliferative neoplasm characterized by hyperactivation of JAK/STAT signaling and dysregulation of the transcription factor GATA1 in megakaryocytes (MKs). TGF-β plays a pivotal role in the pathobiology of MF by promoting BM fibrosis and collagen depos...

Descripción completa

Detalles Bibliográficos
Autores principales: Varricchio, Lilian, Iancu-Rubin, Camelia, Upadhyaya, Bhaskar, Zingariello, Maria, Martelli, Fabrizio, Verachi, Paola, Clementelli, Cara, Denis, Jean-Francois, Rahman, Adeeb H., Tremblay, Gilles, Mascarenhas, John, Mesa, Ruben A., O’Connor-McCourt, Maureen, Migliaccio, Anna Rita, Hoffman, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492354/
https://www.ncbi.nlm.nih.gov/pubmed/34383713
http://dx.doi.org/10.1172/jci.insight.145651
_version_ 1784578910568054784
author Varricchio, Lilian
Iancu-Rubin, Camelia
Upadhyaya, Bhaskar
Zingariello, Maria
Martelli, Fabrizio
Verachi, Paola
Clementelli, Cara
Denis, Jean-Francois
Rahman, Adeeb H.
Tremblay, Gilles
Mascarenhas, John
Mesa, Ruben A.
O’Connor-McCourt, Maureen
Migliaccio, Anna Rita
Hoffman, Ronald
author_facet Varricchio, Lilian
Iancu-Rubin, Camelia
Upadhyaya, Bhaskar
Zingariello, Maria
Martelli, Fabrizio
Verachi, Paola
Clementelli, Cara
Denis, Jean-Francois
Rahman, Adeeb H.
Tremblay, Gilles
Mascarenhas, John
Mesa, Ruben A.
O’Connor-McCourt, Maureen
Migliaccio, Anna Rita
Hoffman, Ronald
author_sort Varricchio, Lilian
collection PubMed
description Myelofibrosis (MF) is a progressive chronic myeloproliferative neoplasm characterized by hyperactivation of JAK/STAT signaling and dysregulation of the transcription factor GATA1 in megakaryocytes (MKs). TGF-β plays a pivotal role in the pathobiology of MF by promoting BM fibrosis and collagen deposition and by enhancing the dormancy of normal hematopoietic stem cells (HSCs). In this study, we show that MF-MKs elaborated significantly greater levels of TGF-β1 than TGF-β2 and TGF-β3 to a varying degree, and we evaluated the ability of AVID200, a potent TGF-β1/TGF-β3 protein trap, to block the excessive TGF-β signaling. Treatment of human mesenchymal stromal cells with AVID200 significantly reduced their proliferation, decreased phosphorylation of SMAD2, and interfered with the ability of TGF-β1 to induce collagen expression. Moreover, treatment of MF mononuclear cells with AVID200 led to increased numbers of progenitor cells (PCs) with WT JAK2 rather than mutated JAK2V617F. This effect of AVID200 on MF PCs was attributed to its ability to block TGF-β1–induced p57(Kip2) expression and SMAD2 activation, thereby allowing normal rather than MF PCs to preferentially proliferate and form hematopoietic colonies. To assess the in vivo effects of AVID200, Gata1(lo) mice, a murine model of MF, were treated with AVID200, resulting in the reduction in BM fibrosis and an increase in BM cellularity. AVID200 treatment also increased the frequency and numbers of murine progenitor cells as well as short-term and long-term HSCs. Collectively, these data provide the rationale for TGF-β1 blockade, with AVID200 as a therapeutic strategy for patients with MF.
format Online
Article
Text
id pubmed-8492354
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-84923542021-10-07 TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis Varricchio, Lilian Iancu-Rubin, Camelia Upadhyaya, Bhaskar Zingariello, Maria Martelli, Fabrizio Verachi, Paola Clementelli, Cara Denis, Jean-Francois Rahman, Adeeb H. Tremblay, Gilles Mascarenhas, John Mesa, Ruben A. O’Connor-McCourt, Maureen Migliaccio, Anna Rita Hoffman, Ronald JCI Insight Research Article Myelofibrosis (MF) is a progressive chronic myeloproliferative neoplasm characterized by hyperactivation of JAK/STAT signaling and dysregulation of the transcription factor GATA1 in megakaryocytes (MKs). TGF-β plays a pivotal role in the pathobiology of MF by promoting BM fibrosis and collagen deposition and by enhancing the dormancy of normal hematopoietic stem cells (HSCs). In this study, we show that MF-MKs elaborated significantly greater levels of TGF-β1 than TGF-β2 and TGF-β3 to a varying degree, and we evaluated the ability of AVID200, a potent TGF-β1/TGF-β3 protein trap, to block the excessive TGF-β signaling. Treatment of human mesenchymal stromal cells with AVID200 significantly reduced their proliferation, decreased phosphorylation of SMAD2, and interfered with the ability of TGF-β1 to induce collagen expression. Moreover, treatment of MF mononuclear cells with AVID200 led to increased numbers of progenitor cells (PCs) with WT JAK2 rather than mutated JAK2V617F. This effect of AVID200 on MF PCs was attributed to its ability to block TGF-β1–induced p57(Kip2) expression and SMAD2 activation, thereby allowing normal rather than MF PCs to preferentially proliferate and form hematopoietic colonies. To assess the in vivo effects of AVID200, Gata1(lo) mice, a murine model of MF, were treated with AVID200, resulting in the reduction in BM fibrosis and an increase in BM cellularity. AVID200 treatment also increased the frequency and numbers of murine progenitor cells as well as short-term and long-term HSCs. Collectively, these data provide the rationale for TGF-β1 blockade, with AVID200 as a therapeutic strategy for patients with MF. American Society for Clinical Investigation 2021-09-22 /pmc/articles/PMC8492354/ /pubmed/34383713 http://dx.doi.org/10.1172/jci.insight.145651 Text en © 2021 Varricchio et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Varricchio, Lilian
Iancu-Rubin, Camelia
Upadhyaya, Bhaskar
Zingariello, Maria
Martelli, Fabrizio
Verachi, Paola
Clementelli, Cara
Denis, Jean-Francois
Rahman, Adeeb H.
Tremblay, Gilles
Mascarenhas, John
Mesa, Ruben A.
O’Connor-McCourt, Maureen
Migliaccio, Anna Rita
Hoffman, Ronald
TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
title TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
title_full TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
title_fullStr TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
title_full_unstemmed TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
title_short TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
title_sort tgf-β1 protein trap avid200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492354/
https://www.ncbi.nlm.nih.gov/pubmed/34383713
http://dx.doi.org/10.1172/jci.insight.145651
work_keys_str_mv AT varricchiolilian tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT iancurubincamelia tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT upadhyayabhaskar tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT zingariellomaria tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT martellifabrizio tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT verachipaola tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT clementellicara tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT denisjeanfrancois tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT rahmanadeebh tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT tremblaygilles tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT mascarenhasjohn tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT mesarubena tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT oconnormccourtmaureen tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT migliaccioannarita tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis
AT hoffmanronald tgfb1proteintrapavid200beneficiallyaffectshematopoiesisandbonemarrowfibrosisinmyelofibrosis